You are connecting from Lake Geneva Public Library, please login or register to take advantage of your institution's Ground News Plan.
Published 2 days ago • loading... • Updated 2 days ago
TelyRx to Present at the Global Technology Virtual Investor Conference July 9th
Sumit Kapur will outline Zapata Quantum’s investor updates and recent milestones, including a $15 million fundraise and a Nature Biotechnology-recognized study.
On Thursday, Zapata Quantum CEO Sumit Kapur and TelyRx Holdings Inc. executives Vanessa Slowey and John Cascio will present live at the Global Technology Virtual Investor Conference hosted by Virtual Investor Conferences and OTC Markets.
Zapata enters the conference following a successful restructuring capped by a $15 million fundraise led by Triatomic Capital, bolstered by a portfolio of more than 60 granted and pending patents.
TelyRx recently reached a milestone of one million prescriptions filled since inception and operates a digital pharmacy platform connecting patients with state-licensed providers to access over 450 medications across 48 U.S. states.
Recognized as one of the Top 10 Papers of 2025 by Nature Biotechnology, Zapata's quantum-enabled drug discovery research provides a proof point for the company's capabilities in generating viable drug candidates in biotech.
Following the live presentations, Kapur will be available for one-on-one investor meetings on July 10 and July 14, with interested parties able to schedule direct engagement through the virtual conference link.